Author: Albadawy, Reda M.; Jadoon, Bismeen A.; Mogahed, Mysara M.; Ibrahim, Mohamed E.; Essawy, Tarek S.; Amin, Ahmed M. A.; Abd-Elraouf, Marwa S.; Elawady, Mona A.
Title: The Impact of Comorbidities on the Outcomes of Egyptian COVID-19 Patients: A Follow-Up Study Cord-id: etybp04i Document date: 2021_6_17
ID: etybp04i
Snippet: OBJECTIVES: This study evaluated the clinical manifestation of COVID-19 and adverse outcomes in patients with comorbidities (outcome: death). METHODS: A comparative follow-up investigation involving 148 confirmed cases of COVID-19 was performed for a month (between April and May 2020) at Qaha Hospital to describe the clinical characteristics and outcomes resulting from comorbidities. Participants were divided into two clusters based on the presence of comorbidities. Group I comprised cases with
Document: OBJECTIVES: This study evaluated the clinical manifestation of COVID-19 and adverse outcomes in patients with comorbidities (outcome: death). METHODS: A comparative follow-up investigation involving 148 confirmed cases of COVID-19 was performed for a month (between April and May 2020) at Qaha Hospital to describe the clinical characteristics and outcomes resulting from comorbidities. Participants were divided into two clusters based on the presence of comorbidities. Group I comprised cases with comorbidities, and Group II included subjects without comorbidity. Survival distributions were outlined for the group with comorbidities after the follow-up period. RESULTS: Fever (74.3%), headache (78.4%), cough (78.4%), sore throat (78.4%), fatigue (78.4%), and shortness of breath (86.5%) were the most prevalent symptoms observed in COVID-19 patients with comorbidities. Such patients also suffered from acute respiratory distress syndrome (37.8%) and pneumonia three times more than patients without comorbidities. The survival distributions were statistically significant (chi-square = 26.06, p ≤ 0.001). CONCLUSION: Multiple comorbidities in COVID-19 patients are linked to severe clinical symptoms, disease complications, and critical disease progression. The presence of one or more comorbidities worsened the survival rate of patients.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and liver ckd disease: 1, 2
- acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung cardiovascular: 1, 2, 3, 4, 5, 6, 7, 8
- acute ards respiratory distress syndrome and lung cardiovascular disease: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lung cardiovascular disease diabetes: 1, 2
- acute ards respiratory distress syndrome and lung infiltrate: 1
- additional impact and liver disease: 1, 2
- additional impact and logistic regression: 1, 2, 3, 4, 5
- liver disease and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- liver disease and lung cardiovascular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- liver disease and lung cardiovascular disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- liver disease and lung cardiovascular disease diabetes: 1, 2, 3, 4, 5
- lobe involvement and logistic regression: 1, 2, 3, 4, 5, 6
- logistic regression and lung cardiovascular disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- logistic regression and lung cardiovascular disease diabetes: 1, 2, 3, 4, 5, 6
- logistic regression and lung infiltrate: 1, 2
Co phrase search for related documents, hyperlinks ordered by date